Real-world Outcomes of Relapsed/Refractory Diffuse Large B-cell Lymphoma Treated with Polatuzumab Vedotin-based Therapy.
Lisa Argnani,Alessandro Broccoli,Cinzia Pellegrini,Alberto Fabbri,Benedetta Puccini,Riccardo Bruna,Maria Chiara Tisi,Francesco Masia,Leonardo Flenghi,Maria Elena Nizzoli,Maurizio Musso,Marilena Salerno,Potito Rosario Scalzulli,Daniela Dessi',Isacco Ferrarini,Elsa Pennese,Elisa Lucchini,Francesca Gaia Rossi,Carla Minoia,Filippo Gherlinzoni,Pellegrino Musto,Caterina Patti,Vittorio Stefoni,Pier Luigi Zinzani HemaSphere（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper